1.58 USD
↗ 0.58 (58.30%)LIVE (AS OF 12:57 PM EDT)
Bluejay Diagnostics, Inc. Common Stock
BJDXNASDAQ • USD
Market: OPEN
Bluejay Diagnostics, Inc. Common Stock (BJDX) is currently trading at $1.58. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 4, 2026.
Open?$1.48
High?$1.76
Low?$1.26
Prev. Close?$1.00
Volume?70.7M
Avg. Volume?6.4M
VWAP?$1.48
Rel. Volume?10.97x
Bid / Ask
Bid?$1.54 × 100
Ask?$1.56 × 100
Spread?$0.02
Midpoint?$1.55
Valuation & Ratios
Market Cap?1.0M
Shares Out?1.0M
Float?2.4M
Float %?90.0%
P/E Ratio?N/A
P/B Ratio?0.25
EPS?-$6.67
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Employees
6
Market Cap
975.0K
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2021-11-10
Address
360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA 01720
Phone: (978) 631-0152
ACTON, MA 01720
Phone: (978) 631-0152
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?-14.00Distress
Confidence?41%Low
Short InterestSqueeze Risk
Short % of Float?24.23%Squeeze Risk
Short Interest?569.7K
Days to Cover?1.0
Free Float2.4M
Avg Daily Volume15.4M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.81Strong
Quick Ratio?2.81Strong
Cash Ratio?2.61Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.25CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-165.1%WEAK▾
S&P3
ROA?-123.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6650642
Enterprise Value?$-2649742
Fundamentals ratios updated end of day